Show simple item record

FieldValueLanguage
dc.contributor.authorChapman, D.G.en
dc.contributor.authorBadal, T.en
dc.contributor.authorKing, G.G.en
dc.contributor.authorThamrin, C.en
dc.date.accessioned2021-06-02T04:55:24Z
dc.date.available2021-06-02T04:55:24Z
dc.date.issued2021
dc.identifier.urihttps://hdl.handle.net/2123/25315
dc.language.isoenen
dc.rightsCopyright All Rights Reserveden
dc.subjectCOVID-19en
dc.subjectCoronavirusen
dc.titleCaution in interpretation of abnormal carbon monoxide diffusion capacity in covid-19 patientsen
dc.typeArticle, Letteren
dc.identifier.doi10.1183/13993003.03263-2020
dc.relation.otherAstraZeneca GlaxoSmithKline, GSK Boehringer Ingelheim National Health and Medical Research Council, NHMRC GlaxoSmithKline Australia, GSKen
usyd.facultySeS faculties schools::Faculty of Medicine and Healthen


Show simple item record

Associated file/s

There are no files associated with this item.

Associated collections

Show simple item record

There are no previous versions of the item available.